 BOSTON, June 01, 2022 GLOBE NEWSWIRE -- Entrada Therapeutics, Inc. Nasdaq: TRDA, a biopharmaceutical company aiming to transform the lives of patients by establishing intracellular Endosomal Escape Vehicle EEVTM therapeutics as a new class of medicines, today announced that the Company will participate in-person at the Goldman Sachs Global Healthcare Conference. A fireside chat with Dipal Doshi, President and Chief Executive Officer will be held at Terranea in Rancho Palos Verdes, CA on Tuesday, June 14, 2022 at 2:40 p.m. Pacific Time5:40 p.m. Eastern Time. 